Chiao-En Wu (Jiao-En Wu, Chao-En Wu)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 49

Top Topics

Locally Advanced

Tyrosine Kinase

Hodgkin Lymphoma

Sentinel Lymph Node

Top Venues

International journal of molecular sciences

Thoracic cancer

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Chia-I Shen, Ju-Chen Chang, Suyog Jain, Steve Olsen, Chiao-En Wu
Afatinib Plus Bevacizumab Treatment for a Patient With EGFR S645C-Mutant Non-Small Cell Lung Cancer: A Case Report. JCO precision oncology 8 (2024)
Ping-Chih Hsu, Bing-Chen Wu, Chin-Chou Wang, Li-Chung Chiu, Chiung-Hsin Chang, Ping-Chi Liu, Chiao-En Wu, Allen Chung-Cheng Huang, Jia-Shiuan Ju, Allen Chung-Cheng Huang, Yu-Ching Lin, Cheng-Ta Yang, How-Wen Ko
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer. Vaccines 12 (5) (2024)
Chia-Min Hung, Chen-Te Wu, Suyog Jain, Chiao-En Wu
Utilizing Plasma-Based Next-Generation Sequencing to Expedite the Diagnostic Process in Suspected Lung Cancer: A Case Report. International journal of molecular sciences 25 (15) (2024)
Chia-I Shen, Ju-Chen Chang, Suyog Jain, Steve Olsen, Chiao-En Wu
Afatinib Plus Bevacizumab Treatment for a Patient With EGFR S645C-Mutant Non-Small Cell Lung Cancer: A Case Report. JCO precision oncology 8 (2024)
Ping-Chih Hsu, Bing-Chen Wu, Chin-Chou Wang, Li-Chung Chiu, Chiung-Hsin Chang, Ping-Chi Liu, Chiao-En Wu, Allen Chung-Cheng Huang, Jia-Shiuan Ju, Allen Chung-Cheng Huang, Yu-Ching Lin, Cheng-Ta Yang, How-Wen Ko
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer. Vaccines 12 (5) (2024)
Chia-Min Hung, Chen-Te Wu, Suyog Jain, Chiao-En Wu
Utilizing Plasma-Based Next-Generation Sequencing to Expedite the Diagnostic Process in Suspected Lung Cancer: A Case Report. International journal of molecular sciences 25 (15) (2024)
Chih-Chun Lee, Sing-Ya Chang, Wen-Chieh Teng, Chih-Ju Wu, Chi-Hung Liu, Szu-Wei Huang, Chiao-En Wu, Kuang-Hui Yu, Tien-Ming Chan
Coexisting Nodular Sclerosis Hodgkin Lymphoma and Kimura's Disease: A Case Report and Literature Review. International journal of molecular sciences 24 (8) (2023)
Wen-Kuan Huang, Shih-Chiang Huang, Chien-Ming Chen, Po Hung Lin, Chiao-En Wu, Cheng-Keng Chuang, Chun-Nan Yeh
Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report. JCO precision oncology 7 (2023)
Wen-Kuan Huang, Shih-Chiang Huang, Chien-Ming Chen, Po Hung Lin, Chiao-En Wu, Cheng-Keng Chuang, Chun-Nan Yeh
Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report. JCO precision oncology 7 (2023)
Chih-Chun Lee, Sing-Ya Chang, Wen-Chieh Teng, Chih-Ju Wu, Chi-Hung Liu, Szu-Wei Huang, Chiao-En Wu, Kuang-Hui Yu, Tien-Ming Chan
Coexisting Nodular Sclerosis Hodgkin Lymphoma and Kimura's Disease: A Case Report and Literature Review. International journal of molecular sciences 24 (8) (2023)
Chih-Chun Lee, Sing-Ya Chang, Wen-Chieh Teng, Chih-Ju Wu, Chi-Hung Liu, Szu-Wei Huang, Chiao-En Wu, Kuang-Hui Yu, Tien-Ming Chan
Coexisting Nodular Sclerosis Hodgkin Lymphoma and Kimura's Disease: A Case Report and Literature Review. International journal of molecular sciences 24 (8) (2023)
Chih-Chun Lee, Sing-Ya Chang, Wen-Chieh Teng, Chih-Ju Wu, Chi-Hung Liu, Szu-Wei Huang, Chiao-En Wu, Kuang-Hui Yu, Tien-Ming Chan
Coexisting Nodular Sclerosis Hodgkin Lymphoma and Kimura's Disease: A Case Report and Literature Review. International journal of molecular sciences 24 (8) (2023)
Qi-An Wang, Huan-Wu Chen, Ren-Chin Wu, Chiao-En Wu
Update of Diagnosis and Targeted Therapy for ALK + Inflammation Myofibroblastic Tumor. Current treatment options in oncology (2023)
John Wen-Cheng Chang, Chien-Jung Huang, Wen-Kuan Huang, Yu-Chao Wang, Jia-Juan Hsieh, Yao-Yu Chang, Yen-Lin Huang, Chia-Ling Wu, Yeh-Han Wang, Shu-Jen Chen, Kien Thiam Tan, Chiao-Ping Chen, Chiao-En Wu
Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma. Clinical & translational immunology 12 (8) (2023)
Wen-Kuan Huang, Shih-Chiang Huang, Chien-Ming Chen, Po Hung Lin, Chiao-En Wu, Cheng-Keng Chuang, Chun-Nan Yeh
Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report. JCO precision oncology 7 (2023)
Chen-Te Wu, Ping-Chih Hsu, John Wen-Cheng Chang, Ching-Fu Chang, Chen-Yang Huang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, Yueh-Fu Fang, Chiao-En Wu
Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR-mutated NSCLC treated with afatinib. Thoracic cancer (2023)
John Wen-Cheng Chang, Ching-Fu Chang, Chen-Yang Huang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, Yueh-Fu Fang, Ping-Chih Hsu, Chiao-En Wu
The survival after discontinuation of EGFR-TKIs due to intolerable adverse events in patients with EGFR-mutated non-small cell lung cancer. Thoracic cancer 14 (4) (2022)
Pei-Shan Tsai, Yu Chen, Shou-Yen Chen, Chung-Yuan Hsu, Chiao-En Wu, Chih-Chun Lee, Tien-Ming Chan
Plasmapheresis for a Patient with Catatonia and Systemic Lupus Erythematosus: A Case Report and Literature Review. Journal of clinical medicine 11 (22) (2022)
Pei-Rung Jan, John Wen-Cheng Chang, Chiao-En Wu
Radiation Recall Pneumonitis: A Rare Syndrome That Should Be Recognized. Cancers 14 (19) (2022)
John Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, Ching-Fu Chang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, Ping-Chih Hsu, Chiao-En Wu
Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients. Thoracic cancer 13 (13) (2022)
Zi-Wei Chen, Gigin Lin, Hsuan-Jen Shih, Chiao-En Wu
Response to Brigatinib Targeted Therapy in Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 19 Deletion, T790M, and cis-C797S Triple Mutations: A Case Report. International journal of molecular sciences 24 (1) (2022)
Zi-Wei Chen, Gigin Lin, Hsuan-Jen Shih, Chiao-En Wu
Response to Brigatinib Targeted Therapy in Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 19 Deletion, T790M, and cis-C797S Triple Mutations: A Case Report. International journal of molecular sciences 24 (1) (2022)
Liang-Wei Tseng, John Wen-Cheng Chang, Chiao-En Wu
Safety of Tepotinib Challenge after Capmatinib-Induced Pneumonitis in a Patient with Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation: A Case Report. International journal of molecular sciences 23 (19) (2022)
John Wen-Cheng Chang, Ching-Fu Chang, Chen-Yang Huang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, Yueh-Fu Fang, Ping-Chih Hsu, Chiao-En Wu
The survival after discontinuation of EGFR-TKIs due to intolerable adverse events in patients with EGFR-mutated non-small cell lung cancer. Thoracic cancer 14 (4) (2022)
John Wen-Cheng Chang, Ching-Fu Chang, Chen-Yang Huang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, Yueh-Fu Fang, Ping-Chih Hsu, Chiao-En Wu
The survival after discontinuation of EGFR-TKIs due to intolerable adverse events in patients with EGFR-mutated non-small cell lung cancer. Thoracic cancer (2022)
Chiao-En Wu, Ching-Fu Chang, Chen-Yang Huang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, Ping-Chih Hsu, John Wen-Cheng Chang
Comparison of Different Tyrosine Kinase Inhibitors for Treatment of Poor Performance Status Patients with EGFR-Mutated Lung Adenocarcinoma. Cancers 14 (3) (2022)
Chi-Yuan Cheng, Chiao-Ping Chen, Chiao-En Wu
Precision Medicine in Cholangiocarcinoma: Past, Present, and Future. Life (Basel, Switzerland) 12 (6) (2022)
Yan-Jei Tang, John Wen-Cheng Chang, Ching-Fu Chang, Chen-Yang Huang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, Yueh-Fu Fang, Ping-Chih Hsu, Chiao-En Wu
Impact of T790M Mutation Status on Later-Line Osimertinib Treatment in Non-Small Cell Lung Cancer Patients. Cancers 14 (20) (2022)
Zi-Ting Chang, Tien-Ming Chan, Chiao-En Wu
EGFR T751_I759delinsN Mutation in Exon19 Detected by NGS but Not by Real-Time PCR in a Heavily-Treated Patient with NSCLC. International journal of molecular sciences 23 (21) (2022)
Zi-Wei Chen, Gigin Lin, Hsuan-Jen Shih, Chiao-En Wu
Response to Brigatinib Targeted Therapy in Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 19 Deletion, T790M, and cis-C797S Triple Mutations: A Case Report. International journal of molecular sciences 24 (1) (2022)
John Wen-Cheng Chang, Ching-Fu Chang, Chen-Yang Huang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, Yueh-Fu Fang, Ping-Chih Hsu, Chiao-En Wu
The survival after discontinuation of EGFR-TKIs due to intolerable adverse events in patients with EGFR-mutated non-small cell lung cancer. Thoracic cancer (2022)
Yau-Ren Chang, Wen-Kuan Huang, Shang Yu Wang, Chiao-En Wu, Jen-Shi Chen, Chun-Nan Yeh
A Nomogram Predicting Progression Free Survival in Patients with Gastrointestinal Stromal Tumor Receiving Sunitinib: Incorporating Pre-Treatment and Post-Treatment Parameters. Cancers 13 (11) (2021)
Chiao-En Wu, Ca Tung Ng, Kien Thiam Tan
Transient Response of Olaparib on Pulmonary Artery Sarcoma Harboring Multiple Homologous Recombinant Repair Gene Alterations. Journal of personalized medicine 11 (5) (2021)
Shin-Yi Chung, Yi-Ping Hung, Yi-Ru Pan, Michael Hsiao, Chiao-En Wu, Dennis Shin-Shian Hsu, Peter Mu-Hsin Chang, Meng-Lun Lu, Chi-Ying F Huang, Yeu Su, Michael Hsiao, Chun-Nan Yeh, Ming-Huang Chen
Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway. Biomedicines 9 (8) (2021)
Chiao-En Wu, Chen-Yang Huang, Chiao-Ping Chen, Yi-Ru Pan, John Wen-Cheng Chang, Jen-Shi Chen, Chun-Nan Yeh, John Lunec
WIP1 Inhibition by GSK2830371 Potentiates HDM201 through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 13 (15) (2021)
Chiao-En Wu, Chun-Nan Yeh
Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial. Biomolecules 11 (11) (2021)
Chiao-En Wu, Wen-Kuan Huang, Wen-Chi Chou, Chia-Hsun Hsieh, John Wen-Cheng Chang, Cheng-Yu Lin, Chun-Nan Yeh, Jen-Shi Chen
Establishment of a Pretreatment Nomogram to Predict the 6-Month Mortality Rate of Patients with Advanced Biliary Tract Cancers Undergoing Gemcitabine-Based Chemotherapy. Cancers 13 (13) (2021)
Chiao-En Wu, Yi-Ru Pan, Chun-Nan Yeh, John Lunec
Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers. Biomolecules 10 (11) (2020)
Yi-Ru Pan, Chiao-En Wu, Ming-Huang Chen, Wen-Kuan Huang, Hsuan-Jen Shih, Keng-Li Lan, Chun-Nan Yeh
Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model. Vaccines 8 (4) (2020)
Chiao-En Wu, Chan-Keng Yang, Meng-Ting Peng, Pei-Wei Huang, Ching-Fu Chang, Kun-Yun Yeh, Chun-Bing Chen, Chih-Liang Wang, Chao-Wei Hsu, I-Wen Chen, Cheng-Tao Lin, Shir-Hwa Ueng, Gigin Lin, Yu-Fen Lin, Chi-Yuan Cheng, John Wen-Cheng Chang
The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies. BMC cancer 20 (1) (2020)
Chiao-En Wu, Ching-Fu Chang, Liao Kou-Sheng, Ju Chiang, Shih-Wei Lee, Yu-Chi Chiu
PD-L1 Immunohistochemistry Comparability and Their Correlation with Clinical Characteristics in NSCLC. Analytical cellular pathology (Amsterdam) 2020 (2020)
Chiao-En Wu, Da-Wei Yeh, Yi-Ru Pan, Wen-Kuan Huang, Ming-Huang Chen, John Wen-Cheng Chang, Jen-Shi Chen, Yu-Chao Wang, Chun-Nan Yeh
Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis. Life (Basel, Switzerland) 10 (11) (2020)
Yi-Ru Pan, Chiao-En Wu, Chun-Nan Yeh
ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner. Biomolecules 10 (11) (2020)
Chiao-En Wu, Ming-Huang Chen, Chun-Nan Yeh
mTOR Inhibitors in Advanced Biliary Tract Cancers. International journal of molecular sciences 20 (3) (2019)
Chiao-En Wu, Chin-Yuan Tzen, Shang Yu Wang, Chun-Nan Yeh
Clinical Diagnosis of Gastrointestinal Stromal Tumor (GIST): From the Molecular Genetic Point of View. Cancers 11 (5) (2019)
Chiao-En Wu, Tsin Shue Koay, Yi-Hsuan Ho, Penny Lovat, John Lunec
TP53 mutant cell lines selected for resistance to MDM2 inhibitors retain growth inhibition by MAPK pathway inhibitors but a reduced apoptotic response. Cancer cell international 19 (2019)
John Wen-Cheng Chang, Yen-Lin Huang, Yao-Yu Chang, Yung-Feng Lo, Tsung-Ying Ho, Yi-Ting Huang, Huan-Wu Chen, Chiao-En Wu
Sentinel Lymph Node Biopsy Was Associated With Favorable Survival Outcomes For Patients With Clinically Node-Negative Asian Melanoma. Cancer management and research 11 (2019)
Shang Yu Wang, Chiao-En Wu, Chun-Chi Lai, Jen-Shi Chen, Chun-Yi Tsai, Chi-Tung Cheng, Ta-Sen Yeh, Chun-Nan Yeh
Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome. Cancers 11 (3) (2019)
Chiao-En Wu, Tsin Shue Koay, Arman Esfandiari, Yi-Hsuan Ho, Penny Lovat, John Lunec
ATM Dependent DUSP6 Modulation of p53 Involved in Synergistic Targeting of MAPK and p53 Pathways with Trametinib and MDM2 Inhibitors in Cutaneous Melanoma. Cancers 11 (1) (2018)